David Greene, California, NPR discussed on Morning Edition


Stories you need to know about that's next time on the California report this is morning edition from NPR news I'm David Greene and I'm no well king good morning when will a covert nineteen vaccine be ready some vaccine developers are already testing on humans but it's probably going to be many months still experts say we need to plan now for the day of vaccine is available and here science correspondent Joe Palca has been talking to them Hey Joe Hey no well still experts say we need to plan now what sort of planning needs to be happening right now well there's a lot to consider maybe we can start with manufacturing okay so let's say a vaccine sales through testing great okay we need a billion doses of it well you can't wait till the end of the testing and say oh yeah I know what you thought of that they're thinking about it now the interesting thing is they are building capacity but companies know and people who are investing in them now Hey we may never days our candidate may never make it so we're building this capacity and it may never be used so it's kind of an interesting conundrum yeah it really is it once we have a vaccine what will early distribution look like who gets it well I talk with a bruise callin about that he's the head of global immunization at the Sabin vaccine institute when vaccines first available the supplies we limited the demand will be a lot more and then how do you manage that Karen Hughes to be in government he says when there was a threat of a major flu pandemic they discussed how to prioritize who goes first clearly among the top where healthcare workers and people who provide community services the things that keeps society going there's the security sector whether that's international security or other military and then there's people who are part of society's critical infrastructure and as we've been learning they may not be the people who necessarily spring to mind as critical but I'm talking about people like grocery store employees and delivery truck drivers and people whose stock shelves and then you've got to think about in health terms so you give it to people who are most vulnerable to give it to the elderly they're they're just not a whole raft of interesting issues that have to be grappled with okay so let's say we get to a day where we've got the vaccine we've gotten to the point where we can mass produce it and then it has to get to people all across the world how is that going to work yeah well you can imagine it's it's a low just tackle challenges of a enormous put front dimensions but it's also a financial challenge I mean this is not going to come for free and the question is okay so developed countries like the United States maybe we can spend billions of dollars but what about low resource countries well we have to figure that out and you know part of it is equity and doing the right thing and part of it is just enlightened self interest because this virus doesn't know anything about global borders and when air travel opens back up again all right you can bring a virus from anywhere in the world anywhere else in the world pretty quick and so it's important to take this as a global problem so experts are talking to you about this they're talking to each other about this are these kinds of discussions happening with governments with our government well absolutely absolutely there are NGOs are involved the international financial organizations of all governments are involved we just had a monkey wrench thrown into the works here a bit it's a little hard to say what the impact will be but a federal scientist named Richard bright who is focused on vaccine development says he was removed from his post as a key post in the vaccine development and he said in a statement that his lawyer has specifically cited pushed back he was pushing back against unproven potential treatments that president trump had repeatedly advocated for during White House briefings now you would think that in a global pandemic situation the World Health Organization might be the coordinating agency for taking care of this but this administration has shown at this stage in our lack of faith in WHL a lot of hurdles and P. are still talking thanks to I'm the US China relationship has become a central issue in the presidential election year and president trump likes to suggest the former vice president Joe Biden is too close to Chinese leaders but the Biden campaign says the president hasn't helped China accountable for the corona virus pandemic here's NPR's us my college when the president is criticized for how he has handled the corona virus outbreak hello often point a finger at China there's nobody ever been tougher on China than me in fact the president says he got elected in twenty sixteen but because of his tough talk on China specifically trait in twenty twenty he's accusing his democratic opponent Joe Biden as being weak on China but the fight over who's tough on China is no longer just about long standing trade concerns it's also about this pandemic that originated in China here's a recent ad from America first a super pacs supporting president trump do.

Coming up next